-+ 0.00%
-+ 0.00%
-+ 0.00%

Keefe, Bruyette & Woods Maintains Outperform on MetLife, Lowers Price Target to $94

Benzinga·07/09/2025 17:27:57
Listen to the news
Keefe, Bruyette & Woods analyst Ryan Krueger maintains MetLife (NYSE:MET) with a Outperform and lowers the price target from $95 to $94.